Retroperitoneal abscess following sclerotherapy for hemorrhoids.
A case report of a patient who underwent submucosal injection sclerotherapy for hemorrhoids is presented. Subsequent necrosis of the underlying tissues produced a rectal perforation and retroperitoneal abscess, which necessitated emergency laparotomy and defunctioning colostomy. Healing of the perforation allowed later closure of the stoma. A brief review of the known complications of this technique has been made. It would appear that necrosis and perforation with abscess formation can be added to this list.
D000038:Abscess / Q000188:drug therapy / Q000209:etiology*; D000328:Adult; D004917:Erythromycin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006484:Hemorrhoids / Q000628:therapy*; D006801:Humans; D007416:Intestinal Perforation / Q000209:etiology; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D012002:Rectal Diseases / Q000209:etiology; D012187:Retroperitoneal Space; D012597:Sclerosing Solutions / Q000009:adverse effects*; D013290:Streptococcal Infections / Q000209:etiology*; D013297:Streptococcus pyogenes
D005839:Gentamicins; D012597:Sclerosing Solutions; D008795:Metronidazole; D004917:Erythromycin